Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7608594 Novobiocin analogues as anticancer agents

Patent 7608594 was granted and assigned to University of Kansas on October, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 3 Jul, 2024

"update inverses"

Golden AI

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12024536 C-terminal HSP90 inhibitors

Edits on 4 Apr, 2024

"update inverses"

Golden AI

edited on 4 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11944631 Combination therapies

Edits on 29 Mar, 2024

"update inverses"

Golden AI

edited on 29 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11939333 Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

Brian S. Blagg0

Len Neckers0

Xiao Ming Yu0

Edits on 16 Sep, 2023

"Add patent abstract"

Golden AI

edited on 16 Sep, 2023

Edits made to:

Article (+320 characters)

Article

Patent abstract

Novel analogues and derivatives of novobiocin are provided, including compounds having modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds of the present invention are useful as heat shock protein 90 inhibitors, and may be used as anticancer and neuroprotective agents.

Edits on 26 Jul, 2023

"update inverses"

Golden AI

edited on 26 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11708319 Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"